With the Zoledronic Acid Market projected to reach USD 5.733 billion by 2035, the competitive landscape is heating up as companies vie for market share. The market is expected to grow at a CAGR of 2.44%, reflecting a growing demand for osteoporosis treatments and advancing applications in oncology. This upward trajectory is primarily due to an increasing awareness of bone health, driven by...